Article info

Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer

Authors

  1. Correspondence to Dr Bente Vilming, Department of Gynecological Oncology, Oslo University Hospital, Oslo, Norway; Bente.Vilming{at}ous-hf.no
View Full Text

Citation

Vilming B, Fallås Dahl J, Bentzen AG, et al
Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer

Publication history

  • Received April 13, 2023
  • Accepted September 6, 2023
  • First published November 24, 2023.
Online issue publication 
December 04, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.